Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
Aged
Colorectal Neoplasms
/ diagnosis
Early Detection of Cancer
/ psychology
Female
Health Promotion
/ methods
Humans
Intention to Treat Analysis
Male
Middle Aged
Occult Blood
Patient Education as Topic
/ methods
Patient Participation
/ statistics & numerical data
Program Evaluation
Prospective Studies
Spain
Telephone
cancer screening
colorectal cancer
early detection of cancer
phone intervention
randomized controlled trial
Journal
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
ISSN: 1463-1318
Titre abrégé: Colorectal Dis
Pays: England
ID NLM: 100883611
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
15
10
2018
accepted:
16
03
2019
pubmed:
18
5
2019
medline:
5
11
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Although colorectal cancer (CRC) screening reduces mortality and morbidity the uptake in target populations is suboptimal. The aim was to assess whether adding a brief phone intervention to the usual invitation process increases participation in a CRC screening programme based in Catalonia. This was a non-blinded prospective randomized control study of patients eligible for their first CRC screening test (immunochemical faecal occult blood test). Between March and December 2017, 512 invitees (age range 50-69 years) were randomized to receiving either a brief informative phone call prior to receiving the standard screening invitation (letter and informative brochure) or the standard screening invitation alone. The primary outcome was participation in the screening programme at 6 months. In all, 492/512 patients (54.7% women; 45.3% men) could be analysed (239/256 intervention group; 253/256 control group). On an intention to treat basis, the intervention group (55% women; 45% men) saw an 11% increase in the participation rate (51.05% vs 40.32%, P = 0.017). The intervention was more effective in male patients (50.93% vs 33.91%, P = 0.01) and those patients aged between 50 and 54 years (54.32% vs 37.77%, P = 0.03). After adjusting for sex, age and geographic area, the benefit of the intervention remained statistically significant (adjusted OR 1.54, 95% CI 1.07-2.20). Our data suggest that a brief, informative intervention by phone in addition to the usual invitation process is effective in increasing participation in a CRC screening programme. It may be a useful strategy to improve uptake in groups which are less likely to participate in CRC screening (clinicaltrials.gov NCT03082911).
Banques de données
ClinicalTrials.gov
['NCT03082911']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1120-1129Subventions
Organisme : REDISSEC (Red de Investigación en Servicios de Salud y Cronicidad)
ID : RD12/001/0007
Organisme : Corporació Sanitària Parc Taulí
Commentaires et corrections
Type : CommentIn
Informations de copyright
Colorectal Disease © 2019 The Association of Coloproctology of Great Britain and Ireland.
Références
International Agency for Research on Cancer. World Health Organization. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012in http://www.iarc.fr/ (most recent consultation, 20 June 2018).
De Angelis R, Sant M, Coleman MP et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2014; 15: 23-34.
Hewitson P, Glasziou PP, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007Issue 1. Art. No.: CD001216.
Shaukat A, Mongin SJ, Geisser MS et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-14.
Ventura L, Mantellini P, Grazzini G et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 2014; 14: 82-6.
Estrategia en Cáncer del Sistema Nacional de Salud. Ministerio de Sanidad y Política Social. Plan de Calidad para el Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Política Social, 2010.
European Commission, International Agency for Research on Cancer. Segnan N, Patnick J, von Karsa L, editors. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st edition. Luxembourg: Office for Official Publication of the European Communities, 2010: 386. ISBN 978-92-79-16574-0 (Electronic version).
Wardle J, Robb K, Vernon S et al. Screening for prevention and early diagnosis of cancer. Am Psychol 2015; 119-33.
Duffy SW, Myles JP, Maroni R et al. Rapid review of evaluation of interventions to improve participation in cancer screening services. J Med Screen 2017; 24: 127-45.
Coronado GD, Rivelli JS, Fuoco MJ et al. Effect of reminding patients to complete fecal immunochemical testing: a comparative effectiveness study of automated and live approaches. J Gen Intern Med 2017; 33: 72-8.
Fortuna RJ, Idris A, Winters P et al. Get screened: a randomized trial of the incremental benefits of reminders, recall, and outreach on cancer screening. J Gen Intern Med 2013; 29: 90-7.
Menon U, Belue R, Wahab S et al. A randomized trial comparing the effect of two phone-based interventions on colorectal cancer screening adherence. Ann Behav Med 2011; 42: 294-303.
Constanza ME, Luckmann R, Stoddard A et al. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect Prev 2007; 31: 191-8.
Dietrich AJ, Tobin JN, Robinson CM et al. Telephone outreach to increase colon cancer screening in Medicaid managed care organizations: a randomized controlled trial. Ann Fam Med 2013; 11: 335-43.
López-Torres-Hidalgo J, Rabanales-Sotos J, Simarro-Herráez MJ et al. Effectiveness of three interventions to improve participation in colorectal cancer screening. Rev Esp Enferm Dig 2016; 108: 315-22.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
Green BB, Wang CY, Anderson ML et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med 2013; 158: 301-11.
Burón A, Grau J, Andreu M et al. Colorectal cancer early screening program of Barcelona, Spain: indicators of the first round of a program with participation of community pharmacies. Med Clin 2015; 145: 141-6.
Milà N, García M, Binefa G et al. Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008. Gac Sanit 2012; 26: 217-22.
Deding U, Henig AS, Salling A et al. Sociodemographic predictors of participation in colorectal cancer screening. Int J Colorectal Dis 2017; 32: 1117-24.
The Helsinki Declaration of the World Medical Association (WMA). Ethical principles of medical research involving human subjects. Pol Merkur Lekarski. 2014; 36: 298-301.
Phillips L, Hendren S, Humiston S, Winters P, Fiscella K. Improving breast and colon cancer screening rates: a comparison of letters, automated phone calls, or both. J Am Board Fam Med 2015; 28: 46-54.
Garcia M, Borràs JM, Milà N et al. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study. Prev Med 2011; 52: 265-7.
Andreu García M, Marzo M, Mascort J et al. Prevention of colorectal cancer. Gastroenterol Hepatol 2009; 32: 137-9.
Gale CR, Deary IJ, Wardle J et al. Cognitive ability and personality predictors of participation in a national colorectal cancer screening program: the English Longitudinal Study of Ageing. J Epidemiol Community Health 2015; 69: 530-5.
Kobayashi LC, Waller J, von Wagner C et al. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey. BMC Public Health 2016; 16: 659.
Denis B, Broc G, Sauleau EA et al. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: a randomized controlled trial. Rev Epidemiol Sante Publique 2017; 651: 17-28.
Deutekom M, van Rijn AF, Dekker E et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health 2009; 19: 400-2.
Weller DP, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97: 1601-5.
Fishman P, Taplin S, Meyer D et al. Cost-effectiveness of strategies to enhance mammography use. Eff Clin Pract 2000; 3: 213-20.
Saywell RM, Champion VL, Skinner CS et al. A cost-effectiveness comparison of three tailored interventions to increase mammography screening. J Womens Health 2004; 13: 909-18.
Lairson DR, DiCarlo M, Myers RE et al. Cost-effectiveness of targeted and tailored intervention on colorectal cancer screening use. Cancer 2008; 4: 779-88.
Posadzki P, Mastellos N, Ryan R et al. Automated telephone communication systems for preventive healthcare and management of long-term conditions. Cochrane Database Syst Rev 2016Issue 12. Art. No.: CD009921.
von Wagner C, Baio G, Raine R et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011; 40: 712-8.
Lo SH, Halloran S, Snowball J et al. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut 2015; 64: 282-91.
Jean-Jacques M, Kaleba EO, Gatta J et al. Program to improve colorectal cancer screening in a low-income racially diverse population: a randomized controlled trial. Ann Fam Med 2012; 10: 412-7.